The Patent Finder

Marker Therapeutics, Inc.

Also on record
Records under this name other than patents Marker Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Marker Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 10,030,252Chimeric Nucleic Acid Molecules with Non-Aug Translation Initiation Sequences and Uses Thereof
Lapsed on the fee record
Ended Jul 24, 2026 · High confidence
Lapsed on the fee recordEnded Jul 24, 2026High confidence
US 9,364,523A chimeric nucleic acid molecule with non-AUG translation initiation sequences
Lapsed on the fee record
Ended Jun 14, 2024 · High confidence
Lapsed on the fee recordEnded Jun 14, 2024High confidence
US 9,988,643Chimeric Nucleic Acid Molecules with Non-Aug Translation Initiation Sequences and Uses Thereof
Lapsed on the fee record
Ended Jun 5, 2022 · High confidence
Lapsed on the fee recordEnded Jun 5, 2022High confidence
US 9,655,956Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof
Lapsed on the fee record
Ended May 23, 2021 · From the USPTO record
Lapsed on the fee recordEnded May 23, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited